백사이트, Inc.
US ˙ NasdaqGS ˙ US92243G1085

SecurityPCVX / Vaxcyte, Inc.
InstitutionRYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity
Latest Disclosed Ownership2,565 shares
Latest Disclosed Value $ 83,388
RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity reports 41.56% increase in ownership of PCVX / Vaxcyte, Inc.

On August 27, 2025 - RYDEX VARIABLE TRUST - Biotechnology Fund Variable Annuity filed a NPORT-P form disclosing ownership of 2,565 shares of Vaxcyte, Inc. (US:PCVX) valued at $83,388 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 29, 2025 disclosing 1,812 shares of Vaxcyte, Inc.. This represents a change in shares of 41.56% during the quarter. The current value of the position is $125,069 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-08-27 2025-06-30 NP Vaxcyte EC US92243G1085 2,565 753 41.56 83 22.06 0.9267
2025-05-29 2025-03-31 NP Vaxcyte EC US92243G1085 1,812 149 8.96 68 -50.00 0.7269
2025-03-03 2024-12-31 NP Vaxcyte EC US92243G1085 1,663 34 2.09 136 -26.88 1.3647
2024-11-29 2024-09-30 NP Vaxcyte EC US92243G1085 1,629 -27 -1.63 186 48.80 1.6860
2024-08-29 2024-06-30 NP Vaxcyte EC US92243G1085 1,656 -570 -25.61 125 -17.76 1.1400
2024-05-30 2024-03-31 NP Vaxcyte EC US92243G1085 2,226 205 10.14 152 20.63 1.2896
2024-02-29 2023-12-31 NP Vaxcyte EC US92243G1085 2,021 -337 -14.29 127 5.00 1.0402
2023-11-29 2023-09-30 NP Vaxcyte EC US92243G1085 2,358 96 4.24 120 7.14 1.0408
2023-08-28 2023-06-30 NP Vaxcyte EC US92243G1085 2,262 295 15.00 113 53.42 0.8915
2023-05-30 2023-03-31 NP Vaxcyte EC US92243G1085 1,967 1,967 74 0.5584
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.